Literature DB >> 24411212

Late ureteral obstruction after injection of dextranomer/hyaluronic acid copolymer.

Samuel Christen1, Mario Mendoza2, Rita Gobet3, Peter Bode4, Daniel Weber3.   

Abstract

Various biological and artificial materials have been introduced for endoscopic treatment of vesicoureteral reflux. Over the past years, dextranomer combined with hyaluronic acid (Dx/Ha) has been established as the most commonly used tissue-augmenting substance for subureteral injection because of its biocompatibility. Nevertheless, the histopathologic analysis of failed Dx/Ha injections showed changes in consistency and volume of the deposit and granulomatous reactions of the adjacent tissue. We report a case of late-onset obstruction 2 years after the injection of Dx/Ha. In the current literature, this potential long-term complication is hardly mentioned.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24411212     DOI: 10.1016/j.urology.2013.10.053

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Changing bulking agent may require change in injection volume for endoscopic treatment of vesicoureteral reflux.

Authors:  Ali Tekin; Ismail Yagmur; Sibel Tiryaki; Zafer Dokumcu; Ibrahim Ulman; Ali Avanoglu
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

2.  Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux.

Authors:  Michelle Lightfoot; Aylin N Bilgutay; Noah Tollin; Scott Eisenberg; Jake Weiser; Leah Bryan; Edwin Smith; James Elmore; Hal Scherz; Andrew J Kirsch
Journal:  Front Pediatr       Date:  2019-09-27       Impact factor: 3.418

3.  Endoscopic correction of vesicoureteral reflux in children using polyacrylate-polyalcohol copolymer (Vantris): 5-years of prospective follow-up.

Authors:  Stanisław Warchoł; Grażyna Krzemień; Agnieszka Szmigielska; Przemysław Bombiński; Krzysztof Toth; Teresa Dudek-Warchoł
Journal:  Cent European J Urol       Date:  2017-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.